Chondrosarcoma Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

• News
• Research
• Blogs
• Clinical Trials

AG-120 in People With IDH1 Mutant Chondrosarcoma
Conditions:   Chondrosarcoma;   Chondrosarcoma, Grade 2;   Chondrosarcoma, Grade 3;   IDH1 Gene Mutation Intervention:   Drug: AG-120 Sponsors:   Memorial Sloan Kettering Cancer Center;   Agios Pharmaceuticals, Inc. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 20, 2020 Category: Research Source Type: clinical trials